GoldBamboo.com - Knowledge is strong medicine
  

The Early High Risk Period for Patients with Heart Failure - Article


  Not Signed In - Sign In / Register






Heart Attack

Acute Myocardial Infraction; Myocardial Infarction


Clinical Trial: The Early High Risk Period for Patients with Heart Failure

This study is currently recruiting patients.
Verified by Royal Brompton Hospital NHS Trust August 2005

Sponsors and Collaborators: Royal Brompton Hospital NHS Trust
Imperial College
Information provided by: Royal Brompton Hospital NHS Trust
ClinicalTrials.gov Identifier: NCT00127322

Purpose

Many people with heart failure either die or are admitted to the hospital in the first few months after the condition is diagnosed. The reasons for this are currently unclear- but may be due to worsening heart failure or other medical conditions such as angina, heart attack or sudden electrical problems of the heart. The investigators propose to recruit and follow-up 450 people, with a new diagnosis of heart failure for a minimum of six months in a multi-centre observational study at two hospital sites: The Hillingdon (Uxbridge) and The Conquest (Hastings) hospitals. The total study duration will be two years. People will be recruited after a diagnosis of heart failure is made and the study will assess reasons for death or admission to hospital and the psychological impact of the condition on both patients and their carers. This is an observational study and no change will be made to patients’ conventional treatment.

Hypotheses:

  1. The high mortality and hospitalisation rate in the early period after diagnosis of heart failure is related to progressive pump failure; or
  2. The high mortality in the early period after the diagnosis of heart failure is related to co-morbid events- principally major coronary events such as myocardial infarction or acute coronary syndrome.

This research should help to identify ways of improving the outlook for people with newly diagnosed heart failure. The analysis of the data generated by this study will be supervised by a statistician. Clinical and demographic data will be described using mean + standard deviation, for continuous variables, and absolute numbers and percentages for categorical variables. Group differences will be examined by t-tests for continuous variables and Chi-square (x2) test for categorical variables. Survival will be reported in terms of Kaplan-Meier curves with differences analysed by Cox proportional hazards.

Condition
Heart Failure, Congestive

MedlinePlus related topics:  Heart Failure

Study Type: Observational
Study Design: Natural History, Longitudinal, Defined Population, Prospective Study

Official Title: The Early High Risk Period for Patients with Incident Heart Failure: A Population Based Study

Further Study Details: 

Expected Total Enrollment:  450

Study start: January 2004;  Expected completion: April 2006
Last follow-up: January 2006;  Data entry closure: February 2006

Eligibility

Ages Eligible for Study:  18 Years and above,  Genders Eligible for Study:  Both
Criteria

Inclusion Criteria:

Exclusion Criteria:

  • Under age of 18 years
  • Unable to give consent

Location and Contact Information

Please refer to this study by ClinicalTrials.gov identifier  NCT00127322

Martin R Cowie, MD MRCP MSc      +442073518856    m.cowie@imperial.ac.uk
Paresh A Mehta, MBCHB MRCP      +442073518856    p.mehta@imperial.ac.uk

United Kingdom
      Hillingdon Hospital, Pield Heath Road, London,  UB8 3NN,  United Kingdom; Recruiting
Simon W Dubrey, MD BSc MRCP  +441895279995 

      The Conquest Hospital, Hastings,  United Kingdom; Recruiting
Hugh F McIntyre, MD FRCP  +441424755255 

Study chairs or principal investigators

Martin R Cowie, MD MRCP MSc,  Principal Investigator,  Imperial College London and Royal Brompton NHS Trust   
Paresh A Mehta, MBChB MRCP,  Principal Investigator,  Imperial College and Royal Brompton Trust   
Simon W Dubrey, MD MRCP,  Principal Investigator,  Hillingdon Hospital NHS Trust   
Hugh F McIntyre, MD FRCP,  Principal Investigator,  East Sussex Hospitals NHS trust   
David M Walker, MD FRCP,  Principal Investigator,  East Sussex Hospitals NHS trust   

More Information

Study ID Numbers:  2003EP005B; PG/03/097
Last Updated:  August 22, 2005
Record first received:  August 3, 2005
ClinicalTrials.gov Identifier:  NCT00127322
Health Authority: United Kingdom: National Health Service
ClinicalTrials.gov processed this record on 2005-08-23


Take control over your directory listings...INSTANTLY

Every day, thousands of users find businesses like yours in the GoldBamboo directory.

Limited Time Offer!!!

For only $50 a year, a savings of 50% off our standard rate:

  • Edit your listing (whenever you want!)
  • Link to your website
  • Choose which categories you are listed in
  • Describe your services

The process will take only a few minutes and consists of 3 easy steps:

1. Register     >     2. Edit Listings     >     3. Publish

Your Company
your street
yourtown, YS 12345
888-888-8888



No Thanks

Popular Treatments

Acne Treatment ADHD Treatment Allergy Treatment Alzheimer's Treatment
Anemia Treatment Arthritis Treatment Asthma Treatment Bipolar Disorder Treatment
Bird Flu Treatment Bladder Cancer Treatment Bladder Control Treatment Blood Pressure Treatment
Brain Tumor Treatment Breast Cancer Treatment Bronchitis Treatment Cancer Treatment
Cancer Alternative Treatment Cataract Treatment Cirrhosis Treatment Colitis Treatment
Colon Cancer Treatment Common Cold Treatment Conjunctivitis Treatment Constipation Treatment
Crohn's Disease Treatment Cystic Fibrosis Treatment Depression Treatment Dermatitis Treatment
Diabetes Treatment Edema Treatment Epilepsy Treatment Erectile Dysfunction Treatment
Fibromyalgia Treatment GERD Treatment Glaucoma Treatment Gout Treatment
Hay Fever Treatment Headache Treatment Heart Disease Treatment Hepatitis Treatment
High Blood Pressure Treatment High Cholesterol Treatment Hives Treatment Hypertension Treatment
Hypoglycemia Treatment IBS Treatment Impotence Treatment Indigestion Treatment
Infertility Treatment Influenza Treatment Insomnia Treatment Lactose Intolerance Treatment
Leukemia Treatment Lung Cancer Treatment Lyme Disease Treatment Macular Degeneration Treatment
Menopause Treatment Migraine Treatment Osteoarthritis Treatment Osteoporosis Treatment
Pancreatic Cancer Treatment PMS Treatment Pneumonia Treatment Prostate Diseases Treatment
Restless Leg Treatment Rheumatoid Arthritis Treatment Sepsis Treatment Sinusitis Treatment
Skin Cancer Treatment Sleep Apnea Treatment Snoring Treatment Stroke Treatment
Testicular Cancer Treatment
GoldBambooTM

Your Integrative Health and Wellness Resource for Heart Attack.

October 12, 2008



Page Updated: May 11, 2006
Disclaimer: All material displayed on the GoldBamboo.com website is provided for educational purposes only. Consult a physician regarding the applicability of any information found on GoldBamboo.com to your symptoms or medical condition.

Massachusetts Law | Home | About Us | Link To Us | Feedback | Disclaimer | Privacy Policy | Terms of Use | Google Co-op | Health Forums

Copyright © 2004-2008 - Gold Bamboo LLC
All rights reserved.

HONcode accreditation seal.

We comply with the HONcode standard for health trust worthy information:
verify here.